# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TX45 is an Fc-relaxin fusion protein being evaluated in patients with Group 2 Pulmonary Hypertension (PH) due to Heart Failure ...
- Bloomberg
Benchmark analyst Nathan Martin reiterates Teck Resources (NYSE:TECK) with a Buy and maintains $55 price target.
RBC Capital analyst Sam Crittenden maintains TECK RESOURCES LIMITED (TSX:TECK) with a Outperform and lowers the price target...
JP Morgan analyst Bill Peterson maintains Teck Resources (NYSE:TECK) with a Overweight and lowers the price target from $56 ...
Teck Resources (NYSE:TECK) reported quarterly earnings of C$0.79 per share which beat the analyst consensus estimate of C$0.69 ...
Rio Tinto (NYSE: RIO) reviews first half of 2021, shows growth in key projects including Simandou in Guinea, Oyu Tolgoi in Mong...
CIBC analyst Bryce Adams maintains Teck Resources (NYSE:TECK) with a Outperformer and raises the price target from C$70 to C$80.
https://news.sky.com/story/rio-tinto-studies-mining-megadeals-after-collapse-of-bhp-anglo-swoop-13176900